Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Oral Microbiol Immunol ; 18(5): 313-7, 2003 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12930524

RESUMO

Porphyromonas gingivalis is a well-adapted pathogen of the periodontal pocket distinguished by its wide array of proteolytic activities and its ability to adhere to multiple substrata in the oral cavity. Microbial proteins with binding functions (such as adhesins and enzymes) very often contain critical tyrosine residues, supported by one or more asparagines in the binding cleft. This study investigates the reduction in adhesiveness and in proteolytic activity after treating P. gingivalis with the tyrosine- and asparagine-targeting enzymes polyphenol oxidase (PPO) and asparaginase (ASG). Cysteine protease activity was reduced by pretreatment with both enzymes, while the trypsin-like activity was affected only by PPO. Adhesion to buccal epithelial cells, laminin and fibronectin as well as hemagglutination was reduced by one or both of the enzymes. PPO, but not ASG, reduced the coaggregation of P. gingivalis with Actinomyces naeslundii. Treatment with these enzymes might provide an alternative to traditional antimicrobial strategies.


Assuntos
Asparaginase/farmacologia , Catecol Oxidase/farmacologia , Porphyromonas gingivalis/efeitos dos fármacos , Fatores de Virulência/antagonistas & inibidores , Actinomyces/efeitos dos fármacos , Aderência Bacteriana/efeitos dos fármacos , Cisteína Endopeptidases/efeitos dos fármacos , Células Epiteliais/microbiologia , Eritrócitos/efeitos dos fármacos , Fibronectinas/efeitos dos fármacos , Hemaglutinação/efeitos dos fármacos , Humanos , Laminina/efeitos dos fármacos , Mucosa Bucal/citologia , Mucosa Bucal/microbiologia , Bolsa Periodontal/microbiologia , Porphyromonas gingivalis/patogenicidade , Tripsina/efeitos dos fármacos
3.
Biochim Biophys Acta ; 1474(2): 212-8, 2000 Apr 06.
Artigo em Inglês | MEDLINE | ID: mdl-10742601

RESUMO

Glycine has been used extensively in bacterial cell surface research. Some researchers employ glycine in growth media so as to increase the transformability of streptococci during electroporation. Others have found that glycine, similar to wall antibiotics, 'weakens' peptidoglycan. It is now shown that when glycine is incorporated into the growth medium, Streptococcus sobrinus exhibits a diminished ability to aggregate with high molecular weight alpha-1,6-glucan. Growth of the bacteria in either a rich or a chemically defined medium results in a cell population with full lectin (glucan-binding) fidelity. Incorporation of glycine, but not serine or other amino acids, at concentrations of 100-200 mM gives rise to bacteria with lowered lectin activities. Bacteriolytic enzymes were able to lyse bacteria from glycine-grown cultures more readily than from cultures without the glycine supplement. The bacteria produce glucan-binding proteins, including glucosyltransferases, but they do not readily aggregate with added dextran. Furthermore, SDS-PAGE gels of supernatants of growth media (+/-glycine) are similar, suggesting the bacteria do not produce a unique set of proteins. Western blotting with a fluorescein isothiocyanate-labeled dextran probe reveals normal amounts of glucan-binding proteins in glycine-grown streptococci. Glycine may be acting as a type of antibiotic, reducing wall integrity upon which glucan promoted cellular aggregation depends.


Assuntos
Proteínas de Bactérias , Glucanos/metabolismo , Glicina/farmacologia , Lectinas/metabolismo , Streptococcus sobrinus/efeitos dos fármacos , Biofilmes , Meios de Cultura , Glucosiltransferases/metabolismo , Fenótipo , Streptococcus sobrinus/enzimologia , Streptococcus sobrinus/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...